Delaware Chapter of the American College of Cardiology

Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) October 25 – 27, 2024!

For more Information and Register: Delaware ACC By the Sea: 2024 Chapter Meeting

Delaware Chapter of the American College of Cardiology

Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

Latest in Cardiology from ACC.org

mTECH AFib: Is a DHT-Enabled Intervention Feasible For AFib Patients?
A randomized controlled trial using a digital health technology (DHT)-enabled intervention is feasible, with high patient retention, engagement and satisfaction, according to the mTECH Afib pilot study published April 30...
ACHD Patients in the CICU Face Worse Outcomes
Patients with adult congenital heart disease (ACHD) have worse outcomes in cardiac intensive care units (CICUs), particularly a high rate of readmissions and mortality, according to a new study published April 30 in JACC: Advances.
Varenicline Plus Behavioral Counseling Increases Abstinence in Youth Who Vape Nicotine
Varenicline, combined with behavioral counseling, is well tolerated and increases vaping cessation compared with placebo in youth who vape nicotine, do not regularly smoke tobacco and want to reduce or quit vaping, according to a randomized trial published April 23...
Lp(a) and CV Risk; CRP Levels and High-Risk Vulnerable Plaque post-NSTEMI; Pulsed Field Ablation vs. Cryoablation for Paroxysmal AFib
In this weekâ€™s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and more vulnerable plaque in patients after non-ST-segment elevation myocardial infarction (STEMI).
Disparities in Hypertension Across Age Spectrum Among Asian American Adults: The Power of Data Disaggregation
There is an increasing appreciation of the racial differences in cardiovascular disease (CVD) risk profiles and subsequent outcomes. This recognition has led to meaningful changes in clinical practice, such as screening for diabetes mellitus earlier...